Stay updated on Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial
Sign up to get notified when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.

Latest updates to the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%
- Check20 days agoChange DetectedAdded new version tag v3.1.0 and removed multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, plus an earlier version v3.0.2). The core effect is a reorganization that reduces coverage of safety topics.SummaryDifference0.2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. No substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%
- Check48 days agoChange DetectedThe webpage has been updated to include new facility names and locations, particularly in Poland, South Korea, and Ukraine, as well as detailed drug information for Cenobamate and related safety information. Several outdated locations and terms have been removed.SummaryDifference16%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenobamate Adjunctive Therapy in PGTC Seizures Clinical Trial page.